Inventor · disambiguated record
Morten Langgård
Also filed as: LANGGAARD MORTEN · LANGGARD MORTEN · LANGGÅRD MORTEN
46 granted patents·4 pending applications·151 citations·filing 2009–2020
97Inventor score
Top patents by PatentIndex Score
50 records- 0197US11026923B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2020·Granted Jun 8, 2021·4 cites·17 claims
- 0297US11026924B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2020·Granted Jun 8, 2021·4 cites·19 claims
- 0396US10351561B2Pyrazolo[3,4-b]pyridines and imidazo[1,5-b]pyridazines as PDE1 inhibitorsH LUNDBECK AS·Filed 2017·Granted Jul 16, 2019·12 cites·21 claims
- 0495US10806718B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2019·Granted Oct 20, 2020·7 cites·16 claims
- 0594US10034861B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2017·Granted Jul 31, 2018·13 cites·28 claims
- 0693US11491140B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2020·Granted Nov 8, 2022·2 cites·20 claims
- 0793US10689379B2Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitorsH LUNDBECK AS·Filed 2019·Granted Jun 23, 2020·6 cites·14 claims
- 0893US10618913B2Macrocycles as PDE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Apr 14, 2020·7 cites·19 claims
- 0993US10512632B21 H-pyrazolo[4,3-B]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Dec 24, 2019·9 cites·13 claims
- 1091US10766893B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Sep 8, 2020·6 cites·19 claims
- 1191US10011606B2Imidazopyrazinones as PDE1 inhibitorsH LUNDBECK AS·Filed 2017·Granted Jul 3, 2018·8 cites·24 claims
- 1291US9533992B2PDE9 inhibitors with imidazo triazinone backboneH LUNDBECK AS·Filed 2016·Granted Jan 3, 2017·10 cites·9 claims
- 1388US10538525B21,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Jan 21, 2020·5 cites·15 claims
- 1487US9850249B2PDE9 inhibitors with imidazo triazinone backboneH LUNDBECK AS·Filed 2016·Granted Dec 26, 2017·6 cites·5 claims
- 1586US10858362B2Imidazopyrazinones as PDE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Dec 8, 2020·2 cites·12 claims
- 1685US11104680B21,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 inhibitorsH LUNDBECK AS·Filed 2019·Granted Aug 31, 2021·1 cites·15 claims
- 1785US10905688B2Combinations comprising substituted imidazo[1,5-α]pyrazinones as PDE1 inhibitorsH LUNDBECK AS·Filed 2017·Granted Feb 2, 2021·2 cites·22 claims
- 1885US9643970B2Substituted imidazo [1,5-a]pyrazines as PDE9 inhibitorsH LUNDBECK AS·Filed 2012·Granted May 9, 2017·8 cites·10 claims
- 1985US9434733B2PDE9 inhibitors with imidazo triazinone backboneH LUNDBECK AS·Filed 2013·Granted Sep 6, 2016·7 cites·4 claims
- 2085US8133897B2Phenylimidazole derivatives as PDE10A enzyme inhibitorsRITZEN ANDREAS·Filed 2009·Granted Mar 13, 2012·10 cites·16 claims
- 2182US9993477B2Substituted imidazo[1,5-a]pyrazines as PDE9 inhibitorsH LUNDBECK AS·Filed 2017·Granted Jun 12, 2018·3 cites·6 claims
- 2280US9701665B2Quinazolin-THF-amines as PDE1 inhibitorsH LUNDBECK AS·Filed 2014·Granted Jul 11, 2017·3 cites·6 claims
- 2379US8865711B2Phenylimidazole derivatives as PDE10A enzyme inhibitorsRITZÉN ANDREAS·Filed 2012·Granted Oct 21, 2014·2 cites·24 claims
- 2478US10633382B2Imidazopyrazinones, pyrazolopyrimidinones and pyrazolopyridinones as PDE1 inhibitorsH LUNDBECK AS·Filed 2017·Granted Apr 28, 2020·2 cites·32 claims
- 2577US10912773B2Combinations comprising substituted imidazo[1,5-a]pyrazinones as PDE1 inhibitorsH LUNDBECK AS·Filed 2017·Granted Feb 9, 2021·2 cites·22 claims
- 2677US9718832B2Hexahydrofuropyrroles as PDE1 inhibitorsH LUNDBECK AS·Filed 2015·Granted Aug 1, 2017·2 cites·16 claims
- 2773US2020375950A11h-pyrazolo[4,3-b]pyridines as pde1 inhibitorsH LUNDBECK AS·Filed 2020·Application pending·0 cites
- 2872US11535611B2Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Dec 27, 2022·1 cites·9 claims
- 2972US9018217B2Phenylimidazole derivatives as PDE10A enzyme inhibitorsLUNDBECK & CO AS H·Filed 2014·Granted Apr 28, 2015·1 cites·29 claims
- 3071US8841297B2Phenylimidazole derivative as PDE10A enzyme inhibitorRITZÉN ANDREAS·Filed 2010·Granted Sep 23, 2014·3 cites·12 claims
- 3170US11472810B2Imidazopyrazinones as PDE1 inhibitorsH LUNDBECK AS·Filed 2020·Granted Oct 18, 2022·0 cites·18 claims
- 3270US10005764B2Halogenated quinazolin-THF-amines as PDE1 inhibitorsH LUNDBECK AS·Filed 2015·Granted Jun 26, 2018·1 cites·15 claims
- 3370US8501795B2(3-aryl-1H-1,2,4-triazol-5-yl)-linked heterocycle derivativesPUESCHL ASK·Filed 2010·Granted Aug 6, 2013·2 cites·25 claims
- 3467US9062060B2Substituted imidazo[2,1-A]isoindoles as PDE10 inhibitorsLUNDBECK & CO AS H·Filed 2014·Granted Jun 23, 2015·0 cites·16 claims
- 3562US8552045B2Tricyclic imidazole compounds as PDE10 inhibitorsKEHLER JAN·Filed 2011·Granted Oct 8, 2013·0 cites·15 claims
- 3660US8796304B2Tricyclic imidazole compounds as PDE10 inhibitorsLUNDBECK & CO AS H·Filed 2013·Granted Aug 5, 2014·0 cites·11 claims
- 3758US9592230B2Substituted imidazoles as PDE10A inhibitorsH LUNDBECK AS·Filed 2015·Granted Mar 14, 2017·0 cites·10 claims
- 3856US9216986B1Quinoline derivatives as PDE10A enzyme inhibitorsLUNDBECK & CO AS H·Filed 2012·Granted Dec 22, 2015·0 cites·10 claims
- 3954US2016318939A1Imidazopyrazinones as PDE1 InhibitorsH LUNDBECK AS·Filed 2016·Application pending·0 cites
- 4053US10526319B2Halogenated quinazolin-THF-amines as PDE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Jan 7, 2020·0 cites·19 claims
- 4153US2017291901A11,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 InhibitorsH LUNDBECK AS·Filed 2017·Application pending·0 cites
- 4251US11634416B2Combination treatments comprising administration of 1H-pyrazolo[4,3-b]pyridinesH LUNDBECK AS·Filed 2018·Granted Apr 25, 2023·0 cites·15 claims
- 4350US10030007B2Quinazolin-THF-amines as PDE1 inhibitorsH LUNDBECK AS·Filed 2017·Granted Jul 24, 2018·0 cites·11 claims
- 4447US10195186B2N-substituted-5-substituted phthalamic acids as sortilin inhibitorsH LUNDBECK AS·Filed 2017·Granted Feb 5, 2019·0 cites·14 claims
- 4546US11851425B2Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridinesH LUNDBECK AS·Filed 2018·Granted Dec 26, 2023·0 cites·15 claims
- 4646US9801878B2Quinoline derivatives as PDE10A enzyme inhibitorsH LUNDBECK AS·Filed 2015·Granted Oct 31, 2017·0 cites·15 claims
- 4745US9669029B2Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitorsH LUNDBECK AS·Filed 2015·Granted Jun 6, 2017·0 cites·13 claims
- 4843US8501797B2(2-aryl-1H-imidazol-4-yl)-linked heterocycle derivativesPUESCHL ASK·Filed 2010·Granted Aug 6, 2013·0 cites·25 claims
- 4941US9096589B2Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitorsPüschl Ask·Filed 2010·Granted Aug 4, 2015·0 cites·20 claims
- 5038US2016311831A1Imidazotriazinones as PDE1 InhibitorsH LUNDBECK AS·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Morten Langgård files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →